---
$id: https://graph.org.ai/products/commodity/51121910
$type: Product
source: UNSPSC
code: "51121910"
title: "Lanatoside c"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lanatoside c

**UNSPSC Code**: 51121910
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lanatoside, digilanide, and cardiac glycoside with the molecular formula C49H76O20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5RR3JFZ771, chemically known as 3-((o beta-d-glucopyranosyl-(1-4)-o-3beta-o-acetyl-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide but generally known as lanatoside c, which bears US NIH Compound Identifier 3879. European Medicines Agency schedules Lanatoside c in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08395MIG. World Health Organization schedules lanatoside c in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lanatoside c under HS 29389010 and SITC 54161. As of Q4 2014, LANATOSIDE C remains the US FDA Preferred Term for this commodity. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(OC7OC(C(O)C(O)C7O)CO)C(OC(=O)C)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CC(O)C1(C(CC2)C1=CC(=O)OC1)C.

